Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
PLoS One ; 8(9): e75733, 2013.
Article in English | MEDLINE | ID: mdl-24069444

ABSTRACT

Systemic inflammatory response syndrome is associated with either fever or hypothermia, but the mechanisms responsible for switching from one to the other are unknown. In experimental animals, systemic inflammation is often induced by bacterial lipopolysaccharide (LPS). To identify the diencephalic and brainstem structures involved in the fever-hypothermia switch, we studied the expression of c-Fos protein, a marker of neuronal activation, in rats treated with the same high dose of LPS (0.5 mg/kg, intravenously) either in a thermoneutral (30 °C) or cool (24 °C) environment. At 30 °C, LPS caused fever; at 24 °C, the same dose caused profound hypothermia. Both fever and hypothermia were associated with the induction of c-Fos in many brain areas, including several structures of the anterior preoptic, paraventricular, lateral, and dorsal hypothalamus, the bed nucleus of the stria terminalis, the posterior pretectal nucleus, ventrolateral periaqueductal gray, lateral parabrachial nucleus, area postrema, and nucleus of the solitary tract. Every brain area studied showed a comparable response to LPS at the two different ambient temperatures used, with the exception of two areas: the dorsomedial hypothalamic nucleus (DMH), which we studied together with the adjacent dorsal hypothalamic area (DA), and the paraventricular hypothalamic nucleus (PVH). Both structures had much stronger c-Fos expression during LPS hypothermia than during fever. We propose that PVH and DMH/DA neurons are involved in a circuit, which - depending on the ambient temperature - determines whether the thermoregulatory response to bacterial LPS will be fever or hypothermia.


Subject(s)
Dorsomedial Hypothalamic Nucleus/metabolism , Neurons/metabolism , Paraventricular Hypothalamic Nucleus/metabolism , Animals , Body Temperature Regulation , Dorsomedial Hypothalamic Nucleus/immunology , Gene Expression , Lipopolysaccharides/immunology , Male , Neurons/immunology , Paraventricular Hypothalamic Nucleus/immunology , Proto-Oncogene Proteins c-fos/genetics , Proto-Oncogene Proteins c-fos/metabolism , Rats , Temperature
2.
Ugeskr Laeger ; 163(3): 287-91, 2001 Jan 15.
Article in Danish | MEDLINE | ID: mdl-11219107

ABSTRACT

We report here that glucagon-like peptide 2(GLP-2) and its receptor constitute a distinct projection system connecting the nucleus of the solitary tract with the dorsomedial hypothalamic nucleus (DMH). The DMH contains a dense plexus of GLP-2 immunoreactive fibres and is the only hypothalamic nucleus expressing GLP-2 receptor mRNA. Consistent with this, central application of GLP-2 activates the expression of neurones solely in the DMH. Furthermore, central administration of GLP-2 causes a dose-related, a pharmacologically and behaviourally specific inhibition of food intake in rats. Surprisingly, the alleged GLP-1 receptor antagonist, Exending (9-39), proved a functional antagonist of centrally applied GLP-2. These data implicate GLP-2 as an important neurotransmitter in the regulation of food intake and likely bodyweight. Our data therefore point to the DMH as a crossroad for endocrine and visceral information affecting feeding behaviour.


Subject(s)
Appetite Regulation/physiology , Gastrointestinal Hormones/physiology , Neurotransmitter Agents/physiology , Peptides/physiology , Receptors, Glucagon/physiology , Animals , Appetite Regulation/drug effects , Brain Stem/immunology , Brain Stem/metabolism , Dorsomedial Hypothalamic Nucleus/immunology , Dorsomedial Hypothalamic Nucleus/metabolism , Gastrointestinal Hormones/administration & dosage , Gastrointestinal Hormones/immunology , Gene Expression , Glucagon-Like Peptide 1 , Glucagon-Like Peptide 2 , Humans , Immunohistochemistry , In Situ Hybridization, Fluorescence , Neurotransmitter Agents/administration & dosage , Neurotransmitter Agents/immunology , Peptides/administration & dosage , Peptides/immunology , RNA, Messenger/genetics , Rats , Rats, Wistar , Receptors, Glucagon/genetics , Receptors, Glucagon/immunology
3.
Cell Tissue Res ; 233(1): 23-33, 1983.
Article in English | MEDLINE | ID: mdl-6616564

ABSTRACT

Recently, the existence of a vasopressin-immunoreactive cell group was described in the bed nucleus of the stria terminalis (van Leeuwen and Caffé 1983). In the present investigation additional nuclei containing vasopressin-immunoreactive cells were found, after colchicine pretreatment, in the dorsomedial hypothalamus, medial amygdaloid nucleus and the locus coeruleus. Vasopressin-immunoreactive cells in the dorsomedial hypothalamus and medial amygdaloid nucleus are small (8--14 micrometers and 10--14 micrometers, respectively), while those in the locus coeruleus are medium-sized (20--25 micrometers). Incubation with anti-bovine neurophysin II and anti-rat neurophysin revealed staining of the same cell group in the above-mentioned areas. None of these cell groups show stained cells after incubation with anti-oxytocin and anti-bovine neurophysin I. When sections of the homozygous Brattleboro rat, which shows a deficiency in vasopressin synthesis, are incubated with anti-vasopressin, anti-bovine neurophysin II, or anti-rat neurophysin, no immunoreactivity can be observed in these brain regions. The above-mentioned cell groups may contribute to the vasopressinergic innervation of brain sites that have been reported to persist after lesioning of the suprachiasmatic, paraventricular and bed nuclei of the stria terminalis.


Subject(s)
Amygdala/immunology , Hypothalamus, Middle/immunology , Locus Coeruleus/immunology , Vasopressins/analysis , Amygdala/cytology , Animals , Dorsomedial Hypothalamic Nucleus/immunology , Histocytochemistry , Hypothalamus, Middle/cytology , Immunochemistry , Locus Coeruleus/cytology , Male , Rats , Rats, Brattleboro , Rats, Inbred Strains , Vasopressins/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...